Get started
Author

Yaru Lin

Observed name: Ya-Ru Lin
ORCID: 0009-0007-0506-5566
Observed ORCID: 0009-0007-0506-5566
OpenAlex ID: A5019740225
Research Trends and Most Influential Clinical Studies on Anti-PD1/PDL1 Immunotherapy for Cancers: A Bibliometric Analysis
2022 · Yanhao Liu, Yan Xu, et al. · Frontiers in Immunology · 34
PDF
Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis
2022 · Yanhao Liu, Xu Cheng, et al. · Frontiers in Immunology · 25
Research landscape and trends of lung cancer radiotherapy: A bibliometric analysis
2022 · Yanhao Liu, Shu Jiang, et al. · Frontiers in Oncology · 12
Integrative eQTL and Mendelian randomization analysis reveals key genetic markers in mesothelioma
2025 · Jinsong Li, Xingmeng Wang, et al. · Respiratory Research · 4
PDF
Precision treatment patterns and prognostic analysis: A retrospective study of small-cell lung cancer
2025 · Yiming Wang, Xi Cheng, et al. · Journal of Cancer Research and Therapeutics · 3
Mitochondrial single-stranded DNA binding protein 1 (SSBP1) high expression as a potential biomarker and association with poor prognosis in hepatocellular carcinoma (HCC)
2025 · Ya-Ru Lin, Jian-Kang Li, et al. · Translational Cancer Research · 3
Establishment and bioinformatics analysis of a four-miRNA prognostic signature for pleural mesothelioma
2024 · Xi Yang, Yaru Lin, et al. · Journal of Cancer · 3
PDF
Identification of a novel prognostic gene signature in pleural mesothelioma: a study based on The Cancer Genome Atlas database and experimental validation
2025 · Xinmeng Wang, Yongqin Yang, et al. · Translational Cancer Research · 1
Investigating the causal role of the pediatric plasma proteome in Kawasaki disease: a Mendelian randomization study
2025 · Yanze Wang, Yaru Lin, et al. · Egyptian Pediatric Association Gazette
PDF
Association Analysis of Four Single Nucleotide Polymorpism(SNP) Variants of the Toll-Like Receptor 4 (TLR4) Gene and Gout in Males of Bai Minority from Dali Prefecture, Yunnan Province, Southwest China
2025 · Wenbing Huang, Wenbing Huang, et al. · Genetic Testing and Molecular Biomarkers
The concomitant of non-classical stereotactic body radiotherapy with tislelizumab based on multidisciplinary modalities for leiomyosarcoma: A case report
2024 · Xiaona Han, Xiaotao Zhang, et al. · Medicine
Works count: 11
Citation count: 85
H-index: 4
I10-index: 3
Year
Topic
Type